Nanoform Finland Oyj (HEL:NANOFH)

Market Cap	104.35M
Revenue (ttm)	2.43M
Net Income (ttm)	-23.07M
Shares Out	85.53M
EPS (ttm)	-0.27
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	57,716
Average Volume	43,265
Open	1.214
Previous Close	1.218
Day's Range	1.206 - 1.230
52-Week Range	1.052 - 3.060
Beta	0.74
RSI	50.04
Earnings Date	Feb 27, 2025

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharmaceutical and biotech industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients, as well as designs and develops nanoformed drug substance. It also offers STARMAP, as a secure online portal to perform large numbers of in-silico CESS experiments The company was founded in 2008 and is headquarte...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 165
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: NANOFH

Financial Performance

In 2023, Nanoform Finland Oyj's revenue was 2.57 million, a decrease of -26.41% compared to the previous year's 3.49 million. Losses were -20.76 million, -5.98% less than in 2022.